Matrix metalloproteinases are associated with severity of disease among COVID-19 patients: A possible pharmacological target.
Basic Clin Pharmacol Toxicol
; 134(5): 727-736, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38468413
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tissue Inhibitor of Metalloproteinase-1
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Basic Clin Pharmacol Toxicol
Journal subject:
FARMACOLOGIA
/
TOXICOLOGIA
Year:
2024
Document type:
Article
Affiliation country:
Brasil
Country of publication:
Reino Unido